InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+20.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hamilton Thomas Edward, Director. Director active across 2 companies, notably Annaly Capital Management INC. Cumulatively, 7 filings have been published. Split: 5 buys · 2 sells. Total volume traded: €3.7m. History available since 3 May 2021. The latest transaction was disclosed on 6 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
50,000 shares@ US$3.3378Common StockSEC:0001193125-26-298523:0
Ideal exit: 2 Apr 2027 (T+270)
57,208 shares@ US$8.7420.2% of flowCommon StockSEC:0001062993-24-011568:0
Ideal exit: 12 Nov 2024 (T+270)
317,460 shares@ US$3.1543.5% of flowCommon StockSEC:0001062993-22-019753:0
Ideal exit: 13 Jun 2023 (T+270)
56,710 shares@ US$8.750.13% mcap50.0% of flowCommon StockSEC:0001192482-21-000601:0
Ideal exit: 27 Mar 2022 (T+270)
56,710 shares@ US$8.7518.2% of flowCommon StockSEC:0001192482-21-000601
Ideal exit: 27 Mar 2022 (T+270)
80,000 shares@ US$9.180450.0% of flowCommon StockSEC:0001628280-21-008886
80,000 shares@ US$9.18040.0039% mcap50.0% of flowCommon StockSEC:0001628280-21-008886:0
7 of 7 declarations
About Hamilton Thomas Edward
Thomas Edward Hamilton is a Board Member at Annaly Capital Management Inc. and Larimar Therapeutics, Inc. He brings expertise in corporate governance and financial strategy. Hamilton plays an active role in overseeing the operations and performance of these companies, contributing to value creation for shareholders.
